1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Cystic Fibrosis (CF) - Epidemiology Forecast to 2030

Cystic Fibrosis (CF) - Epidemiology Forecast to 2030

  • August 2021
  • 41 pages
  • ID: 6134078
  • Format: PDF
  • GlobalData


Table of Contents

Search Inside

Cystic Fibrosis (CF) - Epidemiology Forecast to 2030

Cystic fibrosis (CF) is a progressive, inherited disorder that primarily affects the respiratory and digestive systems.In people with CF, mucus, sweat, and other fluids produced in these systems are sticky and thick, and may obstruct the passageways in the lungs and pancreas (Mayo Clinic, 2021).

Mucus build-up and airway blockages in the lungs cause symptoms such as persistent cough, wheezing, inflamed nasal passages, and recurrent lung infections. Impacts on the digestive system can lead to chronic constipation, intestinal blockages, and weight loss (Mayo Clinic, 2021).

Epidemiologists utilized comprehensive, country-specific data from national CF registries and peer-reviewed journal articles to arrive at a meaningful, in-depth analysis and forecast for the diagnosed prevalent cases of CF.For all the 7MM, CF cases were segmented by age, sex, mutation type, and MRSA infection.

Finally, historical data were evaluated in all 7MM to strengthen the forecast by more accurately capturing changes in prevalence throughout the forecast period.

Epidemiologists forecast that the diagnosed prevalent cases of CF in the 7MM will grow by an annual growth rate (AGR) of 0.51% over the next 10 years, from 69,134 cases in 2020 to 72,659 cases in 2030. For CF mutation type in 2020, the F508del was the most prevalent gene mutation, representing 80.51% of diagnosed prevalent cases of CF in the 7MM. With the more widespread implementation of newborn screening programs, CF is now detected, and thus intervention can begin, earlier than everEpidemiologists expect that continued improvements in the treatment and care of CF patients may drive the number of diagnosed prevalent cases higher as people with CF live longer.

- The Cystic Fibrosis Epidemiology Report provides an overview of the risk factors, comorbidities, and global trends of Cystic Fibrosis (CF) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Canada).
- The report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of CF segmented by age (0-1, 2-5, 6-11, 12-17, 18-29 years, and by 10-year age groups up to 80 years and older) and sex. Diagnosed prevalent cases of CF are further segmented by specific mutation type and chronic methicillin-resistant Staphylococcus aureus (MRSA) infection.
- The CF epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to Buy
The CF Epidemiology series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global CF markets.
- Quantify patient populations in the global CF markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for CF therapeutics in each of the markets covered.
- Understand magnitude of the CF population by age, sex, mutation type, and MRSA infection.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Cystic Fibrosis - Global Drug Forecast and Market Analysis to 2030

  • $ 10995
  • August 2021
  • 122 pages

Cystic Fibrosis - Global Drug Forecast and Market Analysis to 2030 Summary Cystic fibrosis (CF) is an autosomal recessive disease characterized by pancreatic insufficiency and chronic endobronchial ...

  • World
  • Cystic Fibrosis
  • Industry analysis
  • Life Expectancy
  • Prescription Drug Sales


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on